Related references
Note: Only part of the references are listed.Effect of Creatine Monohydrate on Clinical Progression in Patients With Parkinson Disease A Randomized Clinical Trial
Karl Kieburtz et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2015)
The CamPaIGN study of Parkinson's disease: 10-year outlook in an incident population-based cohort
Caroline H. Williams-Gray et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2013)
Prognostic factors of motor impairment, disability, and quality of life in newly diagnosed PD
Daan C. Velseboer et al.
NEUROLOGY (2013)
Disease progress and response to treatment as predictors of survival, disability, cognitive impairment and depression in Parkinson's disease
Thuy C. Vu et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2012)
Progression of motor symptoms in Parkinson's disease
Ruiping Xia et al.
NEUROSCIENCE BULLETIN (2012)
The natural history of treated Parkinson's disease in an incident, community based cohort
Jonathan R. Evans et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2011)
A double-blind, delayed-start trial of rasagiline in Parkinson's disease (the ADAGIO study): prespecified and post-hoc analyses of the need for additional therapies, changes in UPDRS scores, and non-motor outcomes
Olivier Rascol et al.
LANCET NEUROLOGY (2011)
Systematic Review of Levodopa Dose Equivalency Reporting in Parkinson's Disease
Claire L. Tomlinson et al.
MOVEMENT DISORDERS (2010)
Long-term Outcome of Early Versus Delayed Rasagiline Treatment in Early Parkinson's Disease
Robert A. Hauser et al.
MOVEMENT DISORDERS (2009)
A Double-Blind, Delayed-Start Trial of Rasagiline in Parkinson's Disease
C. Warren Olanow et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
The clinical progression of Parkinson's disease
Werner Poewe et al.
PARKINSONISM & RELATED DISORDERS (2009)
Movement Disorder Society-Sponsored Revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): Scale Presentation and Clinimetric Testing Results
Christopher G. Goetz et al.
MOVEMENT DISORDERS (2008)
Selegiline slows the progression of the symptoms of Parkinson disease
S Pålhagen et al.
NEUROLOGY (2006)
Progression of motor impairment and disability in Parkinson disease - A population-based study
G Alves et al.
NEUROLOGY (2005)
The accuracy of diagnosis of parkinsonian syndromes in a specialist movement disorder service
AJ Hughes et al.
BRAIN (2002)
Share Paper
